Summary
Although the use of medication has helped to cure and control disease, it has also led to serious iatrogenic illness. Toxicity is most common and severe in the elderly. Confusion, falls, depression, sedation, deterioration of function, and urinary incontinence and retention are frequently the manifestation of that toxicity. Normal ageing places older patients at risk because of changes in metabolism, distribution, and excretion of drugs, and sensitivity to drug effects is often greater in the elderly. Disease and the interactions of other drugs can increase the incidence and severity of side effects.
Certain drugs should be avoided in the elderly. Those that are long acting and require hepatic metabolism, those with strong anticholinergic properties, and those that are highly sedating tend to cause the most problems. In every case, physicians must weigh the potential benefit of prescribing against the potential risk.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Avorn J, Everitt D, Weiss S. Increased antidepressant use in patients prescribed β-blockers. Journal of the American Medical Association 255: 357–360, 1986
Beaver WT. Analgesic efficacy of dextropropoxyphane and dextropropyxephene-containing correlations: a review. Human Toxicology 3: 1915–2205, 1984
Bellville JW, Forrest Jr WH, Miller E, et al. Influence of age on pain relief from analgesics: a study of postoperative patients. Journal of the American Medical Association 217: 1835–1841, 1971
Berggren D, Gustafson Y, Eriksson B, Bucht G, Hansson LI, et al. Postoperative confusion after anesthesia in elderly patients with femoral neck fractures. Anesthesia and Analgesia 66: 497–504, 1987
Cockcroft DW, Gault MH. Predictions of creatinine clearance from serum creatinine. Nephron 16: 31–41, 1976
Epstein M. Effects of ageing on the kidney. Federation Proceedings 38: 168–172, 1979
Everitt DE, Avorn J. Drug prescribing for the elderly. Archives of Internal Medicine 146: 2393–2396, 1986
Greenblatt DJ. Toxicity of high-dose flurazepam in the elderly. Clinical Pharmacology and Therapeutics 21: 355–361, 1977
Helms PR. Efficacy of antipsychotics in the treatment of the behavioral complications of dementia. Journal of the American Geriatrics Society 33: 206–209, 1985
Lippman S. Drug therapy for depression in the elderly. Postgraduate Medicine 73: 159–173, 1983
Porter J, Jick H. Drug-related deaths among inpatients. Journal of the American Medical Association 237: 879–881, 1977
Rada R, Kellner R. Thiothixene in the treatment of geriatric patients with chronic organic brain syndrome. Journal of the American Geriatrics Society 24(3): 105–107, 1976
Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton 3rd LJ. Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine 316: 363–369, 1987
Soumerai SB, Avoin J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid. New England Journal of Medicine 317: 550–556, 1987
Wetle T (Ed.) Handbook of geriatric care, p. 22, Harvard University, Cambridge, 1982
Willianeson J, Chopin JM. Adverse reaction to prescribed drugs in the elderly. A multi-centre investigation. Age and Ageing 9: 73–80, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beers, M.H., Ouslander, J.G. Risk Factors in Geriatric Drug Prescribing. Drugs 37, 105–112 (1989). https://doi.org/10.2165/00003495-198937010-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198937010-00008